Table 2.
Item | No. of patients | % |
---|---|---|
Concomitant medications | ||
During LCAP | ||
5-ASA | 286 | 95.3 |
Thiopurine | 101 | 33.7 |
Corticosteroid | 183 | 61.0 |
Beginning of the observation period | ||
Corticosteroid | 163 | 54.3 |
During the observation period | ||
5-ASA | 280 | 93.3 |
Thiopurine | 130 | 43.3 |
LCAP treatment status | ||
Number of sessions | ||
5–7 | 46 | 15.8 |
8–9 | 17 | 5.8 |
10 | 228 | 78.4 |
Frequency of LCAP | ||
Weekly | 88 | 30.2 |
Intensive | 203 | 69.8 |
5-ASA 5-aminosalicylic acid, LCAP leukocytapheresis